About Cardiosense
Cardiosense is a healthcare AI company focused on transforming cardiac monitoring and disease management. They leverage wearable sensing technology, advanced signal processing, and deep learning to convert physiological data into actionable clinical insights. Their platform is designed to assist clinicians in detecting, assessing, and managing complex cardiovascular diseases with enhanced precision and accessibility.
The company’s flagship product, CardioTag™, is a noninvasive heart failure monitoring solution that determines Pulmonary Capillary Wedge Pressure (PCWP) at the point of care. This technology aims to eliminate guesswork in managing congestion, which is a significant predictor of hospital readmissions for heart failure patients. The CardioTag™ device and PCWP Analysis Software™ are authorized as Class II medical devices in the US and are intended for prescription use under the supervision of a qualified healthcare professional.
Focus Areas
Business Intelligence
| Technology | AI platform leveraging wearable sensing technology, advanced signal processing, and deep learning to convert raw physiological data into clinical intelligence. Cloud-native approach for data aggregation and analysis. |
What Physicians Need to Know
For physicians, Cardiosense offers a noninvasive, rapid (2-minute recording) method to obtain Pulmonary Capillary Wedge Pressure (PCWP) readings, a critical signal for managing heart failure congestion. This can eliminate guesswork, optimize diuresis protocols, inform discharge decisions, and enable earlier intervention in emergency triage, inpatient management, and outpatient settings. The solution aims to provide validated insights for more informed decisions, potentially reducing 30- to 90-day readmissions by detecting subclinical congestion.
Videos
News, demos, and interviews about Cardiosense.
Videos load interactively. If none appear, search YouTube for Cardiosense →
Frequently Asked Questions
Investors
Who's funded Cardiosense.
Related Companies
GPnotebook is a comprehensive clinical information and educational reference tool designed for healthcare professionals, particularly general practitioners. Established in 2001, it serves as a go-to resource for primary care professionals seeking quick answers to clinical questions during consultations. The platform features over 30,000 concise, evidence-based clinical reference articles, each focused on a specific primary care […]
LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]
Intelligent Medical Objects (IMO) Health is an AI-native clinical data intelligence company that provides a foundation for modern health tech use cases. They leverage a clinician-built ontology and intelligent knowledge graph to create accurate, interoperable, and AI-ready data at scale. IMO Health’s solutions are designed to transform fragmented clinical documentation into structured, contextualized data, which […]
Cloudphysician is a health-tech company that provides AI-powered solutions to transform patient care and safety in intensive care units (ICUs) and emergency departments. The company’s proprietary platform, RADAR, acts as an AI video co-pilot for clinicians, integrating live video, vital signs, and Electronic Medical Records (EMRs) to intelligently interpret events in real-time and guide care […]
Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes. Exo’s technology combines advances […]


